Virginia State Board of Pharmacy v. Virginia Citizens Consumer Council, Inc.
The Court struck down a Virginia law that made it professional misconduct for a licensed pharmacist to advertise prescription drug prices, ruling that the First Amendment protects even purely commercial advertising.
The decision ended a long-standing assumption that 'commercial speech' had no constitutional protection at all, opening the door to advertising rights for a wide range of businesses and eventually professionals.
“What is at issue is whether a State may completely suppress the dissemination of concededly truthful information about entirely lawful activity, fearful of that information's effect upon its disseminators and its recipients.”
The Court frames the core First Amendment question at stake in banning drug price advertising.
How it got here: A three-judge federal district court struck down Virginia's ban on pharmacist price advertising and enjoined its enforcement; the state board appealed directly to the Supreme Court.
The Case in Depth
What happened
A Virginia woman who took daily prescription medication, along with two consumer advocacy groups, sued to challenge a Virginia law making it professional misconduct for a pharmacist to advertise prescription drug prices. Because only licensed pharmacists can dispense such drugs, the law effectively banned all price advertising for prescription medication statewide, even though prices for identical drugs varied enormously from pharmacy to pharmacy.
The question before the Court
Could Virginia ban pharmacists from advertising the prices of prescription drugs?
Why it matters
Consumers—especially the poor, sick, and elderly who rely heavily on prescription drugs—gained a right to see price information pharmacies had been barred from publishing. The ruling also gave businesses across the economy a new constitutional argument against advertising restrictions, reshaping how states could regulate commercial advertising going forward.
What changes now
The Supreme Court's judgment affirms the district court's injunction, so Virginia can no longer enforce its ban on prescription drug price advertising by pharmacists. This is a final merits decision, not a remand for further fact-finding. The Court expressly left open how its reasoning would apply to advertising by other professions like law and medicine, and preserved room for states to regulate false or misleading commercial advertising, time-place-manner restrictions, and broadcast media issues in future cases.
What this does not decide
The Court expressly limited its holding to advertising by pharmacists selling standardized drug products, and said it was not deciding whether states could regulate advertising by traditional professions like law and medicine, where professional judgment rather than a standardized product is being sold. It also left room for regulating false or misleading advertising and true time-place-manner restrictions.
Concurrences and dissents
Concurrence — Justice Burger
Chief Justice Burger emphasized that the decision deals mainly with advertising the price of prepackaged drugs, not with the compounding function pharmacists used to perform. He stressed that quite different considerations would apply to advertising by lawyers and doctors, whose services involve professional judgment rather than standardized products, and said he doubted courts could easily judge which professional advertising claims are misleading.
Concurrence — Justice Stewart
Justice Stewart wrote to explain why the ruling does not prevent government from regulating false or deceptive advertising. He argued that because commercial advertisers know their own products and can verify their claims, false commercial speech can be regulated more readily than other false statements, without the same risk of chilling truthful expression that applies to press or political speech.
Dissent — Justice Rehnquist
“Under the Court's opinion the way will be open not only for dissemination of price information but for active promotion of prescription drugs, liquor, cigarettes, and other products the use of which it has previously been thought desirable to discourage.”The dissent warns the ruling could open the door to advertising for products society has tried to discourage.
Justice Rehnquist argued the consumers lacked standing because the statute did not stop them from receiving price information by phone or in person, and they were really asserting a pharmacist's right to publish rather than their own right to receive. On the merits, he contended the First Amendment should not override the Virginia Legislature's policy judgment, warned the ruling would inevitably extend to advertising by lawyers, doctors, and even harmful products like liquor and cigarettes, and said such economic regulation questions belong to legislatures, not courts.
How the Court got there
The legal reasoning, step by step
- The Court first asked whether First Amendment protection, if it applies to advertising, belongs only to the pharmacist who might speak or also to the consumers who want to receive the information; relying on earlier cases recognizing a 'right to receive' information, it held consumers could assert the claim even though no pharmacist joined the lawsuit.
- The Court then confronted the long-assumed rule that 'commercial speech'—advertising that does no more than propose a business transaction—gets no First Amendment protection at all, tracing that idea back to a 1942 case and noting the Court had already begun retreating from it in later rulings.
- The Court concluded that speech does not lose protection merely because it is commercial, is sold for profit, or seeks money, and that speech is disqualified from protection only by its content, not by the fact that a subject is commercial.
- Weighing the interests, the Court found that both individual consumers (particularly the poor, sick, and elderly) and society as a whole have a strong interest in the free flow of truthful price information, since informed decisions in a free-enterprise economy depend on it.
- The Court rejected Virginia's justifications for the ban—preserving pharmacists' professionalism and public respect for the profession—as resting on keeping the public ignorant rather than directly ensuring competence, and held that the First Amendment does not allow a state to suppress truthful information about lawful products merely out of concern for how people might react to it.
- Because the ban targeted the content of speech completely rather than serving as a neutral time, place, or manner rule, and because there was no claim the advertising was false, misleading, or promoted an illegal transaction, the Court held the statute violated the First Amendment as applied to pharmacists.
Doctrinal impact
Cases affected by this decision
Limits Valentine v. Chrestensen (316 U.S. 52)
The Court rejected Chrestensen's rule that purely commercial advertising gets no First Amendment protection at all.